Byron Zhu

发表

Loteprednol etabonate suspension 0.2% administered QID compared with olopatadine solution 0.1% administered BID in the treatment of seasonal allergic conjunctivitis: a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.

Xinghuai Sun, Mingzhi Zhang, J. Qu, 2012, Clinical therapeutics.